Dipl. Ing. Martin Piskáček, Dr. rer. nat.
Head of the research group, Martin Piskáček Group: Transcription in Malignant Cells and Immunity
Office: bldg. A18/305
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 6697 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 43
2024
-
Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy
Year: 2024, type: Appeared in Conference without Proceedings
-
Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Year: 2024, type:
-
Harnessing the EphA2 blockade in glioblastoma
Year: 2024, type:
-
Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Year: 2024, type: Appeared in Conference without Proceedings
-
Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity
Molecular Medicine, year: 2024, volume: 30, edition: 1, DOI
2023
-
Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma
Year: 2023, type: Conference abstract
-
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia
Cancer immunology, immunotherapy, year: 2023, volume: 72, edition: 5, DOI
-
Gamma-delta T cells in patients with endometriosis
Year: 2023, type:
-
Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs
Year: 2023, type: Appeared in Conference without Proceedings
-
The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD
The Biochemical journal, year: 2023, volume: 480, edition: 5, DOI